Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Hadassah Medical Organization
Sponsor:
Information provided by (Responsible Party):
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00801372
First received: December 2, 2008
Last updated: September 1, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2020
  Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)